Indication

HER2-positive solid tumor

1 clinical trial

1 product

Clinical trial

A Phase Ib Study to Evaluate Efficacy, Safety and Tolerability of KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor

Status: Completed, Estimated PCD: 2022-09-22

Product